RecruitingNCT05784038

Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)

Observational, Prospective, Cohort Study of Mpox Infection in Brazil - NETPOX Cohort


Sponsor

Hospital Israelita Albert Einstein

Enrollment

80 participants

Start Date

Jul 16, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Untargeted Metabolomics and Viral genomic for people with monkeypox and mpox. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTViral genomic

Evaluation of mpox viral genomic

DIAGNOSTIC_TESTUntargeted Metabolomics

Evaluation of metabolomics of the total plasma, oropharynx, and skin samples.


Locations(3)

Hospital Universitário João de Barros Barreto

Belém, Pará, Brazil

Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil

Hospital Naval Marcílio Dias

Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05784038


Related Trials